Table 4 The relationship between EGFR and FSCN1 in patients with IDC.

From: EGFR conjunct FSCN1 as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer

Group

No.

FSCN1 expression

Negative, n (%)

Positive, n (%)

EGFR (+)

243

117 (48.1%)

126 (51.9%)*

EGFR (−)

224

196 (87.5%)

28 (12.5%)

  1. Note: *P < 0.0001.
Back to article page